New York, New York-- (Newsfile Corp. - March 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...

CASE ALLEGATIONS: TransMedics is a commercial-stage medical technology company that engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics”) ( NASDAQ: TMDX) on behalf ...

Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” fourth-quarter 2024 ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. ("TransMedics") on behalf of those who ...

If you purchased or acquired securities in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...

The Gross Law Firm issues the following notice to shareholders of TransMedics Group, Inc. . Shareholders who purchased shares of ...

TransMedics Group (NASDAQ:TMDX – Get Free Report)‘s stock had its “buy” rating restated by Canaccord Genuity Group in a ...

Outside of the U.S., where OrganOx has a larger footprint, livers account for about 1% of TransMedics Group's sales. If ...

BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated ...

NasdaqGM:TMDX Earnings and Revenue History March 7th 2025 A Closer Look At TransMedics Group's Earnings. One key financial ratio used to measure how well a company converts its pr ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, ...